TD Asset Management »

Tango Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $475k 60k 7.94

More positions owned by TD Asset Management

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Rbc Cad (RY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Canadian Pacific Kansas City (CP)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Meta Platforms Cl A (META)
Canadian Natl Ry (CNI)
Amazon (AMZN)
Enbridge (ENB)
Visa Com Cl A (V)
Broadcom (AVGO)

View all positions for TD Asset Management

Top funds holding Tango Therapeutics

Trv Gp Iv
EcoR1 Capital
FMR
Boxer Capital
Nextech Invest
Southpoint Capital Advisors
T. Rowe Price Investment Management
BlackRock
Vanguard Group
Bain Capital Life Sciences Investors
State Street Corporation
Adage Capital Partners GP
Artal Group
Deerfield Management Company
Soleus Capital Management

View all funds holding Tango Therapeutics